Published Nov 13, 2006

Sam Peltzman on Regulation

Join Sam Peltzman as he delves into the complexities of economic regulation, uncovering the often surprising impacts of risk and incentives on market behavior and innovation, particularly within the pharmaceutical sector, and evaluates the role of private certification versus government standards.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

Richard Epstein on Regulation
Answers 383 questions
Casey Mulligan on Vaccines, the Pandemic, and the FDA
Answers 383 questions
Greg Ip on Foolproof
Answers 383 questions
Robin Feldman on Drugs, Money, and Secret Handshakes
Answers 383 questions
Richard Epstein on Property Rights and Drug Patents
Answers 383 questions
Binyamin Appelbaum on the Economists' Hour
Answers 383 questions
Richard Epstein on the Rule of Law
Answers 383 questions
Nicholas Wapshott on Samuelson and Friedman
Answers 383 questions
Bruce Yandle on Bootleggers and Baptists
Answers 383 questions
Richard Epstein on the Constitution
Answers 383 questions
Robin Hanson on Health
Answers 383 questions
Robin Feldman on Drug Patents, Generics, and Drug Wars
Answers 383 questions
Richard Thaler on Libertarian Paternalism
Answers 383 questions
Steven Levitt on Freakonomics and the State of Economics
Answers 383 questions
Anat Admati on Financial Regulation
Answers 383 questions

Dexa/Russ Roberts

Sam Peltzman on Regulation

Topics covered

Popular Clips

The Power of Incentives

Deregulation and Drug Development

Private Certification

The Cost of Drug Regulation

Evaluating Drug Regulations

Unintended Consequences

The Persistence of Regulations

Drug Safety Mechanisms

Impact of Regulation

The Safety Regulation Debate

The Impact of Regulation

Regulatory Resistance

The Price of Accidents

Rationality and Risk

Episode Highlights

Market Dynamics

Regulation and Innovation

Impact of Regulation

Related Episodes

Richard Epstein on Regulation

Casey Mulligan on Vaccines, the Pandemic, and the FDA

Greg Ip on Foolproof

Robin Feldman on Drugs, Money, and Secret Handshakes

Richard Epstein on Property Rights and Drug Patents

Binyamin Appelbaum on the Economists' Hour

Richard Epstein on the Rule of Law

Nicholas Wapshott on Samuelson and Friedman

Bruce Yandle on Bootleggers and Baptists

Richard Epstein on the Constitution

Robin Hanson on Health

Robin Feldman on Drug Patents, Generics, and Drug Wars

Richard Thaler on Libertarian Paternalism

Steven Levitt on Freakonomics and the State of Economics

Anat Admati on Financial Regulation

Sam Peltzman on Regulation

Topics covered

Popular Clips

Episode Highlights

Market DynamicsSam Peltzman explores the interplay between rationality, risk, and incentives in economic decision-making and regulation. He examines how perceived risks and incentives can lead to unexpected behaviors, challenging traditional regulatory approaches.

Market Dynamics

Regulation and InnovationSam Peltzman examines the intricate dynamics of pharmaceutical regulations and their unintended consequences on innovation and market behavior. He also explores the potential of private certification as an alternative to government-imposed safety standards.

Regulation and Innovation

Impact of RegulationSam Peltzman explores the unintended consequences of regulations, revealing how well-meaning policies can backfire. He discusses the persistence of regulations despite inefficiencies and the methods used to evaluate their impact.

Impact of Regulation

Related Episodes